The Painful Truth

Author of The Painful Truth

Follow Us on FacebookFollow Us on Google+Follow Us on TwitterFollow Us on LinkedInFollow Us on PinterestFollow Us on YouTube
  • Home
  • About
  • Book
  • News
  • Documentary
  • Blog
  • Podcasts
  • Media Room
  • Contact
 RSS

Subscribe to the blog

Poll

What is the greatest priority for changing the way we treat addiction?

View Results

Loading ... Loading ...

Recent Posts

  • Treating Babies with Neonatal Abstinence Syndrome
  • Rare Diseases and Orphan Drugs
  • Marijuana and Pain
  • Virtual Reality Therapy for People in Chronic Pain
  • Breaking Bad 2018
  • Response to People in Pain
  • Everything Isn’t as Perfect as It Seems in Ireland
  • Yes, Restrictions on Opioids Are a Threat to Human Rights
  • David C. Holzman Shatters Addiction Myths
  • Opioid Lawsuits Threaten Lives of Pain Sufferers
  • Utah Opioid Crisis Summit
  • Repeating the Mistakes of the Past
  • Prescription Drug Advertisements
  • Family of Pain
  • The ACPA Presents Programs for Migraine Sufferers

Recent Comments

  • Kenneth R. McClelland on Why Keep a Pain Journal
  • Jim Gibson on Marijuana and Pain
  • John D. Waldron on Breaking Bad 2018
  • Deborah Scheers on Suicide and Chronic Pain
  • Shonya on Response to People in Pain

Archives

  • June 2018 (5)
  • May 2018 (4)
  • April 2018 (4)
  • March 2018 (5)
  • February 2018 (4)
  • January 2018 (4)
  • December 2017 (5)
  • November 2017 (4)
  • October 2017 (4)
  • September 2017 (5)
  • August 2017 (4)
  • July 2017 (5)
  • June 2017 (4)
  • May 2017 (4)
  • April 2017 (5)
  • March 2017 (4)
  • February 2017 (4)
  • January 2017 (4)
  • December 2016 (5)
  • November 2016 (4)
  • October 2016 (6)
  • September 2016 (6)
  • August 2016 (7)
  • July 2016 (9)
  • June 2016 (8)
  • May 2016 (8)
  • April 2016 (7)
  • March 2016 (10)
  • February 2016 (12)
  • January 2016 (9)
  • December 2015 (6)
  • November 2015 (3)
  • October 2015 (3)
  • September 2015 (2)
  • August 2015 (4)
  • July 2015 (5)
  • June 2015 (5)
  • May 2015 (2)

Salt Lake City Tribune Op-Ed Supports Utah House Health Bill 266

June 24, 2017 by Lynn Webster, M.D. Leave a Comment

Salt Lake City Tribune Op-Ed Favors Utah House Health Bill 266 by Dr. Lynn R. Webster @LynnRWebsterMD

Salt Lake City Tribune Publishes an Op-Ed Supporting Utah House Health Bill 266

On June 20, 2017, the Salt Lake City Tribune published an op-ed that I co-authored with some of my colleagues. The commentary is called “Patients should not be stuck with ‘fail first’ medicine,” and we wrote it in response to Utah House Health Bill 266.

What Is Utah House Health Bill 266?

Those who live outside of Utah may not have been following this bill. So let me explain that Utah House Health Bill 266 asks that insurers stop mandating “fail-first,” or step therapy, for patients. There are similar bills throughout the country.

While fail-first therapy saves insurers money, it penalizes patients by making them try cheaper medications before their insurance company will pay for the drug that was originally prescribed. Only after the less expensive drugs fail to work will the insurer pay for the drug that is considered the next “step” up (both in terms of price and possibly effectiveness).

Step therapy can cause patients to go untreated or even cause unnecessary side effects. The approach interferes with health care providers’ ability to treat their patients in the best way that they can, and disrupts the patient/doctor relationship that is such an important part of effective treatment.

Text of the Salt Lake City Tribune Op-Ed

Here is our letter that the Salt Lake City Tribune published:

“Fail-first” therapy

We, the undersigned, are writing in response to House Bill 266, which stalled in the Utah House Health and Human Services Committee during the 2017 legislative session.

HB266 addresses the practice by health insurers of imposing step therapy – also known as “fail first” – which occurs when insurers force patients to try, then fail, on several cheaper medications before the medication their health care provider originally prescribed will be covered. Frequently, this delays access to optimal therapy, prolonging needless suffering while potentially exacerbating a patient’s condition.

Progress of HB266 was stymied due to outcry from insurers, who we know routinely institute protocols that result in rejection or delays in the most effective treatments for their policyholders. The relationship that a patient, especially a patient with chronic illnesses, has with their doctor is a vital one and should not be hindered by insurers. Having to adhere to an insurer’s protocols first, and then the recommendations of their doctors second, creates an even large burden for patients with complex and chronic conditions.

Patients are being forced to take alternative drugs, selected by their insurer, before they are able to take the medication that was originally prescribed to them by their doctor. Investigating the negative impacts of step therapy will bring us closer to changing practices that have resulted in higher long-term health care costs and the unnecessary physical and emotional suffering that patients endure.

The undersigned patient and provider organizations support legislation that will exempt patients from a step therapy protocol under certain circumstances. On behalf of patients with diverse chronic health conditions, we thank you for your continued leadership, and look forward to working with you to improve the efficiency with which practitioners, patients and their families can access safe and effective treatment by changing the current barbaric policy.

 

Henry W. Lim, M.D., president, the American Academy of Dermatology Association; Sharon Korhel, American Association of Diabetes Educators; Laura Keller, director, state government affairs and advocacy, American Diabetes Association; Steven Schultz, state director, advocacy and access, Arthritis Foundation; Marc Watterson, director of government relations, and Laura Western, executive director, American Heart Association of Utah; Kevin Daley, government relations specialist, Coalition for State Rheumatology Organizations; Kate Moss, executive director, Susan G. Komen Utah; Jeanetta Williams, president, NAACP Salt Lake Branch and NAACP Tri-State Conference of Idaho, Nevada and Utah; MaryAnn McCabe, state government relations manager, National Psoriasis Foundation; Jared Hafen, program director, Utah AIDS Foundation; Dr. Doug Powell, president, Utah Dermatology Society; Dr. Lynn R. Webster, past president, American Academy of Pain Medicine

Filed Under: Blog, Pain Management, Pharma Tagged With: drugs, fail therapy, insurance companies, medicine, op-ed, salt lake city tribune, step therapy

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Copyright © 2021 Lynn R. Webster, M.D. | [email protected]